A detailed history of Engineers Gate Manager LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 12,354 shares of SRPT stock, worth $1.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,354
Previous 27,160 54.51%
Holding current value
$1.9 Million
Previous $2.62 Million 38.95%
% of portfolio
0.04%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$93.7 - $141.53 $1.39 Million - $2.1 Million
-14,806 Reduced 54.51%
12,354 $1.6 Million
Q4 2023

Feb 14, 2024

BUY
$67.31 - $124.76 $1.83 Million - $3.39 Million
27,160 New
27,160 $2.62 Million
Q2 2023

Aug 14, 2023

SELL
$106.4 - $157.19 $1.7 Million - $2.51 Million
-15,998 Reduced 52.29%
14,599 $1.67 Million
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $3.11 Million - $4.13 Million
26,465 Added 640.49%
30,597 $4.22 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $416,753 - $545,961
4,132 New
4,132 $535,000
Q2 2022

Aug 15, 2022

SELL
$62.69 - $88.44 $198,225 - $279,647
-3,162 Reduced 32.42%
6,590 $494,000
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $615,838 - $881,775
9,752 New
9,752 $762,000
Q3 2021

Nov 15, 2021

SELL
$65.97 - $92.48 $1.46 Million - $2.04 Million
-22,075 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$69.38 - $86.75 $671,251 - $839,306
9,675 Added 78.02%
22,075 $1.72 Million
Q1 2021

May 17, 2021

BUY
$72.25 - $168.95 $895,900 - $2.09 Million
12,400 New
12,400 $924,000
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $1.01 Million - $1.44 Million
-8,030 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$127.12 - $172.34 $141,230 - $191,469
1,111 Added 16.06%
8,030 $1.13 Million
Q2 2020

Aug 17, 2020

BUY
$93.0 - $171.7 $296,205 - $546,864
3,185 Added 85.3%
6,919 $1.11 Million
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $307,606 - $491,543
3,734 New
3,734 $365,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.5B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.